|1.||Serhan, Charles N: 13 articles (12/2015 - 10/2008)|
|2.||Dalli, Jesmond: 4 articles (07/2015 - 08/2012)|
|3.||Thatcher, Thomas H: 3 articles (12/2015 - 01/2013)|
|4.||Phipps, Richard P: 3 articles (12/2015 - 01/2013)|
|5.||Hsiao, Hsi-Min: 3 articles (12/2015 - 01/2013)|
|6.||Sime, Patricia J: 3 articles (12/2015 - 01/2013)|
|7.||Sun, Wei: 3 articles (11/2014 - 01/2013)|
|8.||Recchiuti, Antonio: 3 articles (07/2014 - 05/2012)|
|9.||Wu, Qingping: 3 articles (01/2014 - 01/2013)|
|10.||Wang, Huiqing: 3 articles (01/2014 - 01/2013)|
01/01/2015 - "This study investigated the protective effects of intravitreal Resolvin D1 (RvD1) against LPS-induced rat endotoxic uveitis (EIU). "
01/01/2012 - "This study investigated whether the administration of resolvin D1 to rats with endotoxininduced uveitis (EIU) ameliorates the immuno-inflammatory profile of the eye. "
01/01/2012 - "Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis."
01/01/2015 - "In this model, intravitreal injection of resolvin D1 (RvD1, 10-100-1000 ng/kg) 1 hour after subcutaneous treatment of Sprague-Dawley rats with lipopolysaccharide (LPS, 200 μg/rat) significantly prevented the development of uveitis into the eye. "
01/01/2015 - "Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages."
12/01/2014 - "We hypothesized that inflammation plays a crucial role in the severity of the abnormal vasoconstriction in PH. The goal of this study was to assess the effects of resolvin D1 (RvD1), a potent anti-inflammatory agent, on the pharmacological reactivity of human pulmonary arteries (HPAs) via an in vitro model of induced hyperreactivity. "
07/01/2015 - "In mice maintained on HFD-sat, fish oil and resolvin D1 restored barrier function and reduced inflammation in the colon but were unable to normalize HOMA-IR. "
01/01/2015 - "Development of an immunomodulatory biomaterial: using resolvin D1 to modulate inflammation."
11/15/2014 - "Inflammation resolution is now known to be an active process involving a new genus of lipid mediators, called "specialized proresolving lipid mediators," that includes resolvin D1 (RvD1). "
07/01/2014 - "Resolvin D1 (RvD1; 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid) is an endogenous immunoresolvent that regulates acute inflammation and orchestrates resolution. "
11/01/2014 - "Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression."
07/01/2015 - "Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function."
07/01/2015 - "This study was designed to determine if Resolvin D1 (RvD1), a pro-resolution metabolite of the omega-3 polyunsaturated fatty acid docosahexaenoic acid, could decrease myocardial infarct size with delivered at the onset of ischemia. "
06/02/2014 - "In netrin-1(+/-) mice, resolvin D1 (RvD1) was less effective in reducing neutrophil influx promoting resolution of peritonitis compared with Ntn1(+/+). "
02/01/2013 - "Treatment with resolvin D1 (RvD1) enhanced resolution of peritonitis, decreased accumulation of apoptotic thymocytes in diabetic mice, and stimulated diabetic macrophage phagocytosis. "
09/01/2008 - "Resolvin D1 and Protectin D1 are potent, endogenous, DHA-derived lipid mediators that attenuate neutrophil migration and tissue injury in peritonitis and ischemia-reperfusion injury. "
07/01/2008 - "Evidence from animal models has indicated that DHA and its derivatives (resolvin D1 and protectin D1) attenuate colitis, peritonitis and ischemic stroke. "
10/01/2015 - "resolvin D1) hasten sepsis resolution. "
03/01/2014 - "These results suggest that resolvin D1 may attenuate the degree of inflammatory reaction in sepsis caused by CLP, without harming the host defense response."
03/01/2014 - "We sought to investigate the effects of resolvin D1 on sepsis and to explore the mechanism of action. "
03/01/2014 - "Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response."
03/01/2014 - "Resolvin D1 treatment improved survival in mice with sepsis induced by CLP, enhanced organism bacterial clearance, suppressed the increase of the numbers of neutrophils in peritoneal lavage fluid, reduced the release of inflammatory cytokines, and decreased the apoptosis rate of CD3(+) T lymphocytes of the thymus. "
|2.||Aspirin (Acetylsalicylic Acid)